MiRNA Expression data from sulfisoxazole-treated breast cancer cell-derived exosome
Ontology highlight
ABSTRACT: Sulfisoxazole, a FDA-approved drug, is a promising repositioned drug candidate for the treatement of various cancers. Therefore we analyzed the gene expression by microarray to identified the up-regulated and down-regulated genes after SFX treatment in breast cancer cell-derived exosomes.
ORGANISM(S): synthetic construct Homo sapiens
PROVIDER: GSE124320 | GEO | 2018/12/24
REPOSITORIES: GEO
ACCESS DATA